Easterling, Thomas <br/><br/>
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.  [electronic resource] 

 -  Lancet (London, England)  Sep 2019 
 - 1011-1021 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(19)31282-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Antihypertensive Agents--administration & dosage<br/>Blood Pressure--drug effects<br/>Female<br/>Humans<br/>Hypertension, Pregnancy-Induced--drug therapy<br/>India--epidemiology<br/>Infant, Newborn<br/>Labetalol--administration & dosage<br/>Methyldopa--administration & dosage<br/>Nifedipine--administration & dosage<br/>Pregnancy<br/>Pregnancy Outcome--epidemiology<br/>Treatment Outcome<br/>Young Adult